Up next

Autoplay

Apalutamide, ADT Improve Outcomes in High-Risk Prostate Cancer Post-Surgery

0 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Neal Shore, MD, FACS, highlights his recent research on the effects of apalutamide plus androgen deprivation therapy on the biochemical recurrence-free rate in patients with high-risk localized prostate cancer who underwent radical prostatectomy.

Show more
0 Comments sort Sort By

Up next

Autoplay